Lal, Himal

Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Lal, H., Cunningham, A. L., Godeaux, O., Chlibek, R., Diez-Domingo, J., Hwang, S.-J., Levin, M. J., McElhaney, J. E., Poder, A., Puig-Barberà, J., et al. (2015) · New England Journal of Medicine

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 1,454

Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older

Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 1,070

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial

Maréchal, C., Lal, H., Poder, A., Ferguson, M., Enweonye, I., Heineman, T. C., Hervé, C., Rheault, P., Talli, J., Wauters, D., et al. (2018) · Vaccine

Herpesvirus Infections and TreatmentsImmune responses and vaccinations

Cited by 36

Adjuvanted Herpes Zoster Subunit Vaccine in Older Adults

Lal, H., Cunningham, A. L., & Heineman, T. C. (2015) · New England Journal of Medicine

Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research

Cited by 33

Safety and immunogenicity of a herpes zoster subunit vaccine in Japanese population aged ≥50 years when administered subcutaneously vs. intramuscularly

Vink, P., Shiramoto, M., Ogawa, M., Eda, M., Douha, M., Heineman, T., & Lal, H. (2017) · Human Vaccines & Immunotherapeutics

Herpesvirus Infections and TreatmentsIntramuscular injections and effects

Cited by 26